Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q9C0D2: Variant p.Pro562Leu

Centrosomal protein of 295 kDa
Gene: CEP295
Feedback?
Variant information Variant position: help 562 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Proline (P) to Leucine (L) at position 562 (P562L, p.Pro562Leu). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Similar physico-chemical property. Both residues are medium size and hydrophobic. The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -3 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description: help In SCKL11; likely pathogenic; loss of function in centriole replication and ciliogenesis; the variant is unable to rescue centriole and ciliary defects in patient-derived cells. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 562 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 2601 The length of the canonical sequence.
Location on the sequence: help RAQLEEEKRKKTQPTGVGIA P ASCPVISDEDSHRQMIRNYQ The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human                         RAQLEEEKRKKTQPTGVGIAPASCPVISDEDSHRQMIRNYQ

Mouse                         RAQLEEQRKQADQPE-VCCAPMSHAMISDEDSHRQMIRNYQ

Rat                           QAQLEETRKQADHLE-VRPAPVSHAMISDEERHRQMIRNYQ

Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 2601 Centrosomal protein of 295 kDa
Alternative sequence 1 – 1988 Missing. In isoform 4.
Alternative sequence 1 – 1772 Missing. In isoform 2.



Literature citations
Bi-allelic variants in CEP295 cause Seckel-like syndrome presenting with primary microcephaly, developmental delay, intellectual disability, short stature, craniofacial and digital abnormalities.
Li N.; Xu Y.; Chen H.; Lin J.; Al Abdi L.; Bekheirnia M.R.; Li G.; Gofin Y.; Bekheirnia N.; Faqeih E.; Chen L.; Chang G.; Tang J.; Yao R.; Yu T.; Wang X.; Fu W.; Fu Q.; Shen Y.; Alkuraya F.S.; Machol K.; Wang J.;
EBioMedicine 99:104940-104940(2024)
Cited for: VARIANTS SCKL11 544-GLN--CYS-2601 DEL; LEU-562 AND 1520-ARG--CYS-2601 DEL; INVOLVEMENT IN SCKL11; CHARACTERIZATION OF VARIANT SCKL11 LEU-562; FUNCTION;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.